Giving postpartum mothers with hepatitis C the opportunity to start antiviral treatment while still in the hospital after giving birth — and delivering the medication to their bedside before discharge ...
Harm reduction programs have saved lives, reduced hospitalizations and emergency department (ED) visits and prevented hepatitis C (HCV) cases, according to a new modeling study by the Michigan ...
Gilead Sciences, Inc. (Nasdaq: GILD) will present new findings from its antiviral research and development programs at IDWeek, taking place October 19-22 in Atlanta, GA. Data from 34 presentations ...
Gilead Sciences, Inc. (Nasdaq: GILD) will present new research that reinforces its commitment to advancing innovation for ...
Liver stiffness measurement after success with oral antivirals predicts HCC risk, particularly among patients with advanced chronic liver disease.
Judge said no evidence to support claims of kickbacks on Harvoni, Sovaldi Whistleblower will appeal, his lawyers say Gilead settled claims of kickbacks on HIV drugs earlier this year Sept 12 (Reuters) ...
Liver cancer is considered one of the rarer types of cancer in Germany, but the number of new cases is increasing. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback